| Code | CSB-RA016127MB1HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is developed as a research-grade biosimilar to NP-137, targeting Netrin-1 (NTN1), a secreted laminin-related guidance molecule that plays crucial roles in axonal guidance, cell migration, and tissue morphogenesis during development. NTN1 functions by binding to its receptors, including DCC and UNC5 family members, to regulate neuronal navigation and vascular patterning. Beyond its developmental functions, NTN1 has emerged as a significant factor in cancer biology, where it promotes tumor cell survival, angiogenesis, and metastasis by inhibiting apoptosis in various malignancies including colorectal, breast, and pancreatic cancers. Dysregulated NTN1 expression has also been implicated in inflammatory diseases and fibrotic conditions.
The reference antibody NP-137 has been utilized in preclinical research to investigate NTN1-mediated signaling pathways and evaluate therapeutic strategies for blocking NTN1-dependent tumor progression. This biosimilar provides researchers with a reliable tool for studying Netrin-1 biology, examining its role in developmental processes, investigating cancer-associated mechanisms, and exploring potential therapeutic interventions targeting the NTN1 signaling axis.
There are currently no reviews for this product.